4-(4-BROMOPHENYL)-3-PYRIDINECARBOXALDEHYDE
- $140.68 - $488
- Product name: 4-(4-BROMOPHENYL)-3-PYRIDINECARBOXALDEHYDE
- CAS: 376646-65-0
- MF: C12H8BrNO
- MW: 262.1
- EINECS:
- MDL Number:MFCD01310797
- Synonyms:4-(4-Bromophenyl)nicotinaldehyde;4-(4-BROMOPHENYL)PYRIDINE-3-CARBOXALDEHYDE;4-(4-BROMOPHENYL)-3-PYRIDINECARBOXALDEHYDE;3-Pyridinecarboxaldehyde, 4-(4-bromophenyl)-
4 prices
Selected condition:
Brand
- Atlantic Research Chemicals
- Crysdot
- Matrix Scientific
- SynQuest Laboratories
Package
- 1g
- 250mgs:
- ManufacturerAtlantic Research Chemicals
- Product numberAH00245
- Product description4-(4-Bromophenyl)nicotinaldehyde 95%
- Packaging250mgs:
- Price$140.68
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11133131
- Product description4-(4-Bromophenyl)nicotinaldehyde 97%
- Packaging1g
- Price$302
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number081631
- Product description4-(4-Bromophenyl)nicotinaldehyde 97%
- Packaging1g
- Price$488
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H15-9-00
- Product description4-(4-Bromophenyl)pyridine-3-carboxaldehyde
- Packaging1g
- Price$336
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Atlantic Research Chemicals | AH00245 | 4-(4-Bromophenyl)nicotinaldehyde 95% | 250mgs: | $140.68 | 2021-12-16 | Buy |
Crysdot | CD11133131 | 4-(4-Bromophenyl)nicotinaldehyde 97% | 1g | $302 | 2021-12-16 | Buy |
Matrix Scientific | 081631 | 4-(4-Bromophenyl)nicotinaldehyde 97% | 1g | $488 | 2021-12-16 | Buy |
SynQuest Laboratories | 4H15-9-00 | 4-(4-Bromophenyl)pyridine-3-carboxaldehyde | 1g | $336 | 2021-12-16 | Buy |
Properties
Boiling point :390.2±32.0 °C(Predicted)
Density :1.490±0.06 g/cm3(Predicted)
pka :3.49±0.18(Predicted)
Density :1.490±0.06 g/cm3(Predicted)
pka :3.49±0.18(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|